Providing a forum for innovative cancer researchers around the world, Singapore will hold its 11th Frontiers in Cancer Science (FCS) conference from November 4-6 at Academia at SingHealth.
The conference is jointly organized by the Cancer Science Institute of Singapore, Duke-NUS Medical School, Genome Institute of Singapore, Institute of Molecular and Cell Biology, Lee Kong Chian School of Medicine, National Cancer Centre Singapore, and National University Cancer Institute, Singapore.
This annual conference started in 2009 as a one-day symposium for the common purpose of sharing and advancing knowledge locally as well with the global scientific community. It has now grown into a major international cancer conference, with more than 500 participants registering annually. It is the largest cancer conference in Singapore and regularly brings together cancer researchers and cancer physicians to share their pioneering ideas and novel information in an interactive and network-building environment. Highlights of the previous FCS conferences can be seen here.
FCS 2019 brings together a stellar list of international and local distinguished cancer researchers covering all aspects of cancer research, with complementary knowledge and expertise. They include the 2018 Nobel Laureate Gregory Winter, CBE, FRS, FMedSci, along with Ira Mellman, PhD, of Genentech; Yinon Ben-Neriah, MD, PhD, of the Israel Cancer Research Fund; Sankar Ghosh, PhD, of Columbia University, and many others. Advances in both basic science and clinical realms will be presented. There will also be the opportunity for young investigators to showcase their work, and selected talks from poster abstracts will be presented at the lightning-talks sessions. Prizes will also be awarded for the best short talks and posters.
This year, our partner, the American Association of Cancer Research (AACR), will once again sponsor the poster prizes. Two travel awards worth $2,000 each for two meritorious poster presenters at the FCS 2019 will support travel to the 2020 AACR Meeting in San Diego.
Program highlights, as well as information about registration and abstract submission, are available here.
Kanaga Sabapathy, PhD, received his doctoral degree in Cellular Immunology from the Institute for Molecular & Cellular Biology, Singapore, in 1995. His postdoctoral work was conducted at the Institute of Molecular Pathology in Vienna. He moved to the National Cancer Centre Singapore (NCCS) in 1999 as the Principal Investigator of the Laboratory of Molecular Carcinogenesis. Since 2013, he has been the head of the Division of Cellular & Molecular Research, and the Director of Planning and Strategy at NCCS. He is also a professor and Deputy Director of the Cancer and Stem Cell Biology Programme at Duke-NUS; the research director of the Academic Clinical Program in Oncology at SingHealth-Duke-NUS; a joint professor with the Department of Biochemistry at NUS and a joint research director at the IMCB. He is a Fellow of the Royal College of Pathologists and a member of the AACR, and is a recipient of the National Research Foundation’s Investigatorship award.
You may also like: